Market open · Delayed intraday data · 11:43 AM ET
Last update: Oct 20, 2026, 11:42 AM ET
Equifax Inc.
$177.17▲ 11.73% today
Market Open

Why Equifax Inc. (EFX) stock moved

Updated Oct 20, 2026

Equifax Inc. (EFX) shares climbed 11.7% to $177.17 as of October 20, 2026, a sharp gain from the prior close of $158.57. BestStocks flagged the session as a major change for EFX. Below, we break down what changed for EFX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

EFX climbed 11.7% to $177.17

Equifax reported Q3 2026 earnings and revenues that beat analyst estimates, with 10% year-over-year revenue growth driven by 8% growth in Diversified Markets despite a weak U.S. mortgage market, according to PR Newswire and Zacks. The company also returned $158 million in cash to shareholders. EFX surged 9.88% to $174.23. Next earnings announcement scheduled for February 3, 2027; consensus EPS estimate of $2.22 for the next period.

This summary describes the catalyst and move as first detected on Oct 20, 2026, 10:02 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
Source: zacks.com
ActivityLow confidence
Rel. volume
0.9×
Below Avg
Vs peers
—
No comparable peers
Market cap
$20.8B
New York Stock Exchange
Analyst target
$202
+14.2% vs price
Price chart
Sep 21 – Oct 20
VNVNNNVVVEF$137$157$178Sep 21Sep 28Oct 6Oct 13Oct 20
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Equifax Inc. investors

For Equifax Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Strong 11.7% price move; Equifax reported Q3 2026 earnings and revenues that beat analyst estimates, with 10% year-over-year revenue growth driven by 8% growth in Diversified Markets despite a weak U.S. mortgage market, according to PR Newswire and Zacks. Weighing against that: Equifax Inc. moved -4.47% intraday from $145.78 to $139.27; Equifax filed a material event on Form 8-K today, triggering a 6.89% intraday decline to $174.16. Wall Street's consensus price target sits at $202.31, implying +14.2% upside from $177.17. Over the past 90 days analysts logged 1 upgrade and 1 downgrade. BestStocks rates the overall signal quality low (58/100). With earnings roughly 106 days out, the next report is the most likely near-term test of the move.

EFX price reaction

EFX last traded at $177.17, up $18.60 (+11.73%) from the previous close of $158.57. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $137.24 and $177.17, and it currently sits about 100% of the way up that band.

Bullish and bearish analyst opinions on Equifax Inc. (EFX)

Latest catalyststrengthens the bull case
The latest catalyst — a materially positive development — it strengthens the bull case and confirms the prevailing bullish analyst lean.

The consensus analyst price target on Equifax Inc. (EFX) is $202.31, 14.2% above the recent $177.17. Over the past 90 days analysts logged 1 upgrade, 13 maintains, and 1 downgrade. Here is how the bullish and bearish cases on EFX line up.

The bullish case

  • Wall Street's consensus price target of $202.31 implies +14.2% upside from $177.17.
  • The Street's most bullish target is $245.00 (+38.3%).
  • 1 analyst upgrade in the past 90 days, most recently Rothschild & Co to Buy (2026-08-21).
  • Strong 11.7% price move.
  • Equifax reported Q3 2026 earnings and revenues that beat analyst estimates, with 10% year-over-year revenue growth driven by 8% growth in Diversified Markets despite a weak U.S. mortgage market, according to PR Newswire and Zacks.

The bearish case

  • The most bearish analyst target is $148.00 (-16.5%).
  • 1 analyst downgrade in the past 90 days, most recently Oppenheimer to Perform (2026-10-16).
  • Equifax Inc. moved -4.47% intraday from $145.78 to $139.27.
  • Equifax filed a material event on Form 8-K today, triggering a 6.89% intraday decline to $174.16.
  • Equifax stock fell 6.08% to $169.13 following the company's July 21 earnings report, which beat Q2 expectations (EPS $2.25 vs. $2.21 consensus) but issued downbeat full-year guidance of $6.71B–$6.78B, well below Wall Street's $7.39B consensus (PRNewswire).
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish
The latest catalyst moved the balance toward the bulls — the hollow tick marks where it sat before.

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Oct 20, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $202+14.2%
↑ 1 upgrades= 13 maintains↓ 1 downgrades
Mizuho maintained Outperform · 2026-10-19
SEC filings watch
8-K2026-10-20
Material event — review for impact
high
8-K2026-07-29
Material event — review for impact
high
8-K2026-07-21
Material event — review for impact
high
10-Q2026-07-21
Quarterly financial results
medium
Peer context
EFX+11.7%

Previous notable changes for EFX

Filings2026-10-20+11.7%
Equifax Inc. (EFX) filed a new 8-K on 2026-10-20. We checked news, earnings announcements, analyst updates, and corporate actions — the specific content of the filing was not disclosed in available sources.
News2026-10-16-0.0%
Equifax expands Mastercard Open Finance collaboration to offer lenders consumer-permissioned cash flow data alongside credit data.
Valuation2026-10-15+7.2%via zacks.com ↗
Equifax rose 6.36% to $159.93 ahead of third-quarter earnings scheduled for October 20, according to the web catalyst and Zacks preview. Positioning activity reflects investor focus on Wall Street's $2.20 EPS consensus estimate and revenue outlook of $1.69 billion, alongside sentiment around recent product launches including the Mortgage Ultimate platform and expanded Work Number adoption. Volume traded 1,054,569 shares (0.85x historical average at this time of day), consistent with normal pre-earnings consolidation.
News2026-10-13+1.2%
Equifax launched Mortgage Ultimate with adaptive automation achieving 95% fulfillment rate for lenders.

In-depth EFX event analyses

Permanent, dated analyses of EFX's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2027-02-03 (est.)
in 106 days
Thesis shift
Neutral / Mixed
bullish signal
Risk level
High
from change events

Frequently asked questions about EFX

Why did Equifax Inc. (EFX) stock move?

EFX climbed 11.7% to $177.17. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did EFX stock rise?

EFX gained 11.73% ($18.60) versus the prior close of $158.57, last trading at $177.17 on 0.9× average volume.

When is Equifax Inc.'s next earnings date?

EFX's next earnings report is estimated for 2027-02-03 — about 106 days away.

What is the analyst price target for EFX?

The consensus analyst price target for EFX is $202.31, about 14.2% above the current $177.17. Over the past 90 days, analysts recorded 1 upgrade, 13 maintains, and 1 downgrade.

How BestStocks tracks EFX

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared EFX-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for EFX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 20, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsCompany news feedsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.